Oracle Alpha’s Organon & Co OGN Stock Holding History

Oracle Alpha’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$289K	Buy	15,371 +1,538	+11%	+$26.4K	0.52%	84
2023 Q4	$199K	Buy	+13,833	New	+$188K	0.26%	190

Other funds holding OGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

SPC

Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SSM

Sound Shore Management Greenwich, Connecticut $2.98B AUM 22.67% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Oracle Alpha's OGN Position: Q1 2024 in Review

Oracle Alpha increased its Organon & Co (OGN) stake by 11% in Q1 2024, buying an estimated $26.4K and bringing the position to 15,371 shares worth $289K. The position accounts for 0.52% of the portfolio, ranked #84.

Oracle Alpha first reported a position in OGN in Q4 2023 and has held it in 2 quarters since. 720 funds tracked by Wall St. Rank hold OGN as of Q1 2024.

Oracle Alpha held 15,371 shares of Organon & Co worth $289K as of Q1 2024.
Oracle Alpha bought 1,538 Organon & Co shares in Q1 2024, an estimated $26.4K.
Organon & Co made up 0.52% of Oracle Alpha's portfolio in Q1 2024, its #84 holding.
Oracle Alpha first reported a position in Organon & Co in Q4 2023 and has held it in 2 quarters since.
720 funds tracked by Wall St. Rank held Organon & Co as of Q1 2024.

Based on Oracle Alpha's 13F filing for Q1 2024, filed 15 May 2024.